retatrutide vs zepbound Tirzepatide vs Semaglutide Compared Retatrutide 2026: 28.7% Weight Loss

Theres evidence of metabolic and cardiometabolic benefits , beyond just weight change

Evidence Builds The SURMOUNT-OSA trial, funded by Eli Lilly, added to this evidence

In 2026, none of the Bridge drugs are subject to an MFP

If pancreatitis is confirmed, the treatment should not be resumed, and GLP-1 RAs should not be started in patients with a history of pancreatitis [128]

If it helps manage and prevent those life-threatening risks, then for that patient it is probably better to continue it. The TGA said it first became aware of the link to NAION in 2024 after a study published in a peer-reviewed medical journal raised concerns, and further evidence of the potential links has since been closely monitored

The catch